AlzeCure is sponsored by           

 

Medical technologies

AlzeCure is developing a novel medical technology that will enable accurate measurement of relevant biomarkers.

The monitoring of theragnostic biomarkers in clinical trials is pivotal for concept evaluation and drug development. Therefore, we are developing an innovative biosensor technology to enable local determination of biomarkers levels with high resolution in various tissue fluids for use in multiple indications. The project involves key collaborations within the fields of affinity chemistry, biosensing & medical devices.